Skip to main content
Download PDF

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts

Journal of Translational Medicine volume 19, Article number: 266 (2021) Cite this article

The Original Article was published on 04 May 2021

Correction to: J Transl Med (2021) 19:192 https://doi.org/10.1186/s12967-021-02860-z

In the original publication [1] there was an incorrect funding section. The incorrect and correct funding information is published in this correction article. The original article has been updated.


Incorrect funding

  • This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number HI20C1496), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007291) and (No. NRF-2018R1C1B6005889).


Correct funding

  • This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number HI20C1496, HI15C3062), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007291) and (No. NRF-2018R1C1B6005889).

Reference

  1. Moon J, Lee S, Choi JW, Lee AR, Yoo JH, Moon S-J, Park S-H, Cho ML. Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. J Transl Med. 2021;19:192. https://doi.org/10.1186/s12967-021-02860-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Jeonghyeon Moon and Seon-yeong Lee contributed equally to this work

Authors and Affiliations

  1. Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea

    Jeonghyeon Moon & Mi-La Cho

  2. Rheumatism Research Center, College of Medicine, Catholic Research Institute of Medical Science, The Catholic University of Korea, 222 Banpo-Daero, Seocho-gu, Seoul, 06591, Republic of Korea

    Seon-yeong Lee, Jeong Won Choi, A. Ram Lee, Jin Hee Yoo & Mi-La Cho

  3. Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea

    A. Ram Lee & Mi-La Cho

  4. Divison of Rheumatology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, 11765, Republic of Korea

    Su-Jin Moon

  5. Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea

    Sung-Hwan Park

  6. Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea

    Mi-La Cho

Authors
  1. Jeonghyeon Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seon-yeong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeong Won Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Ram Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jin Hee Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Su-Jin Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sung-Hwan Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mi-La Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mi-La Cho.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moon, J., Lee, Sy., Choi, J.W. et al. Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. J Transl Med 19, 266 (2021). https://doi.org/10.1186/s12967-021-02916-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12967-021-02916-0

Journal of Translational Medicine

ISSN: 1479-5876

Contact us